doi: 10.1007/s004390050323.
Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29, within a 3-Mb YAC contig
Affiliations
- PMID: 9003507
- DOI: 10.1007/s004390050323
Item in Clipboard
Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29, within a 3-Mb YAC contig
Hum Genet.
1997 Jan.
Abstract
Dominant optic atrophy, type Kjer, is an autosomal dominant eye disease that is characterized by progressive optic atrophy with onset in early childhood, decrease of visual acuity, colour vision defects and centrocecal scotoma. By examination of 5 Danish families and the use of polymorphic markers, we have refined the localization of the OPA1 locus and assigned it to a 1.4-cM interval on chromosome 3q28-3q29, between markers D3S3669 and D3S3562. This localizes the gene on a 3-Mb YAC contig covering the disease locus. We have also located a possible candidate gene HRY to this contig.
Similar articles
-
Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.J Med Genet. 1998 Oct;35(10):793-800. doi: 10.1136/jmg.35.10.793. J Med Genet. 1998. PMID: 9783700 Free PMC article. Review.
-
Saturating density of STSs (1/6 kb) in a 1.1 Mb region on 3q28-q29: a valuable resource for cloning of disease genes.Eur J Hum Genet. 2001 Apr;9(4):307-10. doi: 10.1038/sj.ejhg.5200630. Eur J Hum Genet. 2001. PMID: 11313765
-
Demonstration of a founder effect and fine mapping of dominant optic atrophy locus on 3q28-qter by linkage disequilibrium method: a study of 38 British Isles pedigrees.Hum Genet. 1998 Jan;102(1):79-86. doi: 10.1007/s004390050657. Hum Genet. 1998. PMID: 9490303
-
Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis.Hum Mol Genet. 1994 Jun;3(6):977-80. doi: 10.1093/hmg/3.6.977. Hum Mol Genet. 1994. PMID: 7951248
-
A review of primary hereditary optic neuropathies.J Inherit Metab Dis. 2003;26(2-3):209-27. doi: 10.1023/a:1024441302074. J Inherit Metab Dis. 2003. PMID: 12889662 Review.
Cited by
-
Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.J Med Genet. 1998 Oct;35(10):793-800. doi: 10.1136/jmg.35.10.793. J Med Genet. 1998. PMID: 9783700 Free PMC article. Review.
-
Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter.Doc Ophthalmol. 1998-1999;95(3-4):217-28. doi: 10.1023/a:1001844021014. Doc Ophthalmol. 1998. PMID: 10532406
-
OPA1, a molecular regulator of dilated cardiomyopathy.J Cell Mol Med. 2023 Oct;27(20):3017-3025. doi: 10.1111/jcmm.17918. Epub 2023 Aug 21. J Cell Mol Med. 2023. PMID: 37603376 Free PMC article. Review.
-
Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicing.BMC Med Genet. 2017 Feb 28;18(1):22. doi: 10.1186/s12881-017-0383-x. BMC Med Genet. 2017. PMID: 28245802 Free PMC article.
-
Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%.BMC Med Genet. 2012 Aug 2;13:65. doi: 10.1186/1471-2350-13-65. BMC Med Genet. 2012. PMID: 22857269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
